Striatal D(2)/D(3) receptor availability is inversely correlated with cannabis consumption in chronic marijuana users.

scientific article

Striatal D(2)/D(3) receptor availability is inversely correlated with cannabis consumption in chronic marijuana users. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.DRUGALCDEP.2012.07.016
P932PMC publication ID3532956
P698PubMed publication ID22909787
P5875ResearchGate publication ID230713379

P50authorChristine HerringQ79370072
Karmen K. YoderQ87217774
P2093author name stringPatrick D Skosnik
Daniel S Albrecht
Qi-Huang Zheng
Jennifer M Vollmer
Bruce H Mock
Elizabeth A Patton
Kevin M Perry
Margaret S Brumbaugh
Lauren A Federici
P2860cites workCannabinoid receptor localization in brainQ24558751
The endocannabinoid system as a target for the treatment of cannabis dependenceQ24648135
The assessment and analysis of handedness: The Edinburgh inventoryQ26778476
Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletionQ28257109
AddictionQ29029757
Determination and characterization of a cannabinoid receptor in rat brainQ29618888
Cannabis use disrupts eyeblink conditioning: evidence for cannabinoid modulation of cerebellar-dependent learningQ30481477
Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbensQ30499463
Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk?Q33211909
Incentive-sensitization and addictionQ34140682
Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokersQ34199610
Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brainQ34230368
A 18F-MPPF PET normative database of 5-HT1A receptor binding in men and women over agingQ34473208
Chronic use of marijuana decreases cannabinoid receptor binding and mRNA expression in the human brainQ34601740
Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.Q34602111
Consensus nomenclature for in vivo imaging of reversibly binding radioligandsQ34630958
Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysisQ34631075
Test-retest variability of [¹¹C]raclopride-binding potential in nontreatment-seeking alcoholics.Q34799404
Can recreational doses of THC produce significant dopamine release in the human striatum?Q34987781
Reliability of striatal [¹¹C]raclopride binding in smokers wearing transdermal nicotine patchesQ35580378
Dopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography studyQ35857033
Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistryQ38331458
Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's diseaseQ40298357
Low platelet monoamine oxidase activity and chronic marijuana useQ41816079
Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomographyQ42379921
Simultaneous determination of delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol in human plasma by solid-phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometryQ43765479
Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortexQ43812676
Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain.Q43873792
Effects of alcohol detoxification on dopamine D2 receptors in alcoholics: a preliminary studyQ44245935
Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanismQ44346123
Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatumQ44351037
Neuromorphological background of cannabis addictionQ44494962
Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET studyQ44790762
Delta 9-tetrahydrocannabinol induces dopamine release in the human striatumQ46406572
Alcohol dependence is associated with blunted dopamine transmission in the ventral striatumQ46600038
Role of monoamine oxidase type A and B on the dopamine metabolism in discrete regions of the primate brainQ47686071
Effect of selegiline on dopamine concentration in the striatum of a primateQ48285752
Psychophysiological evidence of altered neural synchronization in cannabis use: relationship to schizotypyQ48407943
Cannabinoid self-administration increases dopamine release in the nucleus accumbens.Q48413058
Validation of Large White Pig as an animal model for the study of cannabinoids metabolism: application to the study of THC distribution in tissuesQ48465618
PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeysQ48475729
Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET studyQ48481156
Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysisQ48655780
Cannabis extract, but not Δ1-tetrahydrocannabinol, inhibits human brain and liver monoamine oxidaseQ48690582
Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjectsQ48725501
Decreases in dopamine receptors but not in dopamine transporters in alcoholicsQ48846413
Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivoQ48909879
History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availabilityQ48918346
Affect processing and positive syndrome schizotypy in cannabis users.Q50886573
Dopamine transporter and D2-receptor density in late-onset alcoholism.Q51978154
Striatal dopaminergic D(2) receptor density measured by [(123)I]iodobenzamide SPECT in the prediction of treatment outcome of alcohol-dependent patients.Q52277869
Quantitative measurement of Δ9-tetrahydrocannabinol and two major metabolites in physiological specimens using capillary column gas chromatography negative ion chemical ionization mass spectrometryQ67301987
Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependenceQ72635469
Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawalQ73029501
P433issue1-2
P921main subjectstriatumQ1319792
P304page(s)52-57
P577publication date2012-08-19
P1433published inDrug and Alcohol DependenceQ5308875
P1476titleStriatal D(2)/D(3) receptor availability is inversely correlated with cannabis consumption in chronic marijuana users
P478volume128

Reverse relations

cites work (P2860)
Q38789021A review of positron emission tomography studies exploring the dopaminergic system in substance use with a focus on tobacco as a co-variate
Q27324505Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses
Q51539430An Information Theoretical Study of the Epistasis Between the CNR1 1359 G/A Polymorphism and the Taq1A and Taq1B DRD2 Polymorphisms: Assessing the Susceptibility to Cannabis Addiction in a Turkish Population.
Q47809583Cannabinoid transmission in the prefrontal cortex bi-phasically controls emotional memory formation via functional interactions with the ventral tegmental area.
Q56505162Cannabis Addiction and the Brain: a Review
Q50082799Chronic Δ9-THC in Rhesus Monkeys: Effects on Cognitive Performance and Dopamine D2/D3 Receptor Availability
Q34002281Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity
Q37276855Deficits in striatal dopamine release in cannabis dependence
Q59791239Effects of sedative drug use on the dopamine system: a systematic review and meta-analysis of in vivo neuroimaging studies
Q37281925Effects of smoking on D₂/D₃ striatal receptor availability in alcoholics and social drinkers
Q57813712Genetic Predisposition vs Individual-Specific Processes in the Association Between Psychotic-like Experiences and Cannabis Use
Q30422045Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity
Q52674788Mechanisms Underlying Sex Differences in Cannabis Use.
Q37657596Neuroimaging in Alcohol and Drug Dependence
Q36030702Neuroimaging of the dopamine/reward system in adolescent drug use.
Q35576598Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications.
Q36915496Reduced sleep duration mediates decreases in striatal D2/D3 receptor availability in cocaine abusers.
Q37437144Salience attribution and its relationship to cannabis-induced psychotic symptoms.
Q35950793Striatal D(2/3) Binding Potential Values in Drug-Naïve First-Episode Schizophrenia Patients Correlate With Treatment Outcome
Q21559698Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings
Q22251015The dopamine theory of addiction: 40 years of highs and lows
Q37441554The effects of Δ9-tetrahydrocannabinol on the dopamine system.
Q39290095The impact of adolescent exposure to medical marijuana laws on high school completion, college enrollment and college degree completion
Q44459554The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study.
Q57811188The neuropsychopharmacology of cannabis: a review of human imaging studies
Q33820114The role of cannabinoid transmission in emotional memory formation: implications for addiction and schizophrenia

Search more.